435 related articles for article (PubMed ID: 19275709)
81. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold.
Ibrahim TS; Salem IM; Mostafa SM; El-Sabbagh OI; ElKhamisi MKM; Hegazy L; Elgendy B
Bioorg Chem; 2020 Jul; 100():103878. PubMed ID: 32361486
[TBL] [Abstract][Full Text] [Related]
82. Novel anti-inflammatory agents based on pyrazole based dimeric compounds; design, synthesis, docking and in vivo activity.
Tewari AK; Srivastava P; Singh VP; Singh A; Goel RK; Mohan CG
Chem Pharm Bull (Tokyo); 2010 May; 58(5):634-8. PubMed ID: 20460788
[TBL] [Abstract][Full Text] [Related]
83. Synthesis of novel 1,3,4-oxadiazole derivatives and their biological properties.
Husain A; Ajmal M
Acta Pharm; 2009 Jun; 59(2):223-33. PubMed ID: 19564146
[TBL] [Abstract][Full Text] [Related]
84. Synthesis, evaluation and modeling of some triazolothienopyrimidinones as anti-inflammatory and antimicrobial agents.
Bekhit AA; Farghaly AM; Shafik RM; Elsemary MM; El-Shoukrofy MS; Bekhit AEA; Ibrahim TM
Future Med Chem; 2017 Jun; 9(9):881-897. PubMed ID: 28635307
[TBL] [Abstract][Full Text] [Related]
85. Synthesis of new pyrazolo[3,4-d]pyrimidine derivatives and evaluation of their anti-inflammatory and anticancer activities.
Abd El Razik HA; Mroueh M; Faour WH; Shebaby WN; Daher CF; Ashour HMA; Ragab HM
Chem Biol Drug Des; 2017 Jul; 90(1):83-96. PubMed ID: 28032452
[TBL] [Abstract][Full Text] [Related]
86. Ligand based design and synthesis of pyrazole based derivatives as selective COX-2 inhibitors.
Murahari M; Mahajan V; Neeladri S; Kumar MS; Mayur YC
Bioorg Chem; 2019 May; 86():583-597. PubMed ID: 30782576
[TBL] [Abstract][Full Text] [Related]
87. Antibacterial and molecular docking studies of newly synthesized nucleosides and Schiff bases derived from sulfadimidines.
Amer HH; Eldrehmy EH; Abdel-Hafez SM; Alghamdi YS; Hassan MY; Alotaibi SH
Sci Rep; 2021 Sep; 11(1):17953. PubMed ID: 34504157
[TBL] [Abstract][Full Text] [Related]
88. Design, synthesis and molecular docking study of some substituted 4,5- dihydro-2H-indazole derivatives as potential anti-inflammatory agents.
Badr MH; Elbayaa RY; El-Ashmawy IM
Med Chem; 2013 Aug; 9(5):718-30. PubMed ID: 23061568
[TBL] [Abstract][Full Text] [Related]
89. Analogue-based design, synthesis and molecular docking analysis of 2,3-diaryl quinazolinones as non-ulcerogenic anti-inflammatory agents.
Manivannan E; Chaturvedi SC
Bioorg Med Chem; 2011 Aug; 19(15):4520-8. PubMed ID: 21724403
[TBL] [Abstract][Full Text] [Related]
90. New benzothiophene derivatives as dual COX-1/2 and 5-LOX inhibitors: synthesis, biological evaluation and docking study.
El-Miligy MM; Hazzaa AA; El-Messmary H; Nassra RA; El-Hawash SA
Future Med Chem; 2017 Apr; 9(5):443-468. PubMed ID: 28362117
[TBL] [Abstract][Full Text] [Related]
91. Synthesis and Biological Evaluation of New Diarylpyrazole and Triarylimidazoline Derivatives as Selective COX-2 Inhibitors.
Abdellatif KRA; Abdelgawad MA; Labib MB; Zidan TH
Arch Pharm (Weinheim); 2017 Aug; 350(8):. PubMed ID: 28605057
[TBL] [Abstract][Full Text] [Related]
92. Synthesis, in vitro and in vivo biological evaluation, COX-1/2 inhibition and molecular docking study of indole-N-acylhydrazone derivatives.
Moraes ADTO; Miranda MDS; Jacob ÍTT; Amorim CADC; Moura RO; Silva SÂSD; Soares MBP; Almeida SMV; Souza TRCL; Oliveira JF; Silva TGD; Melo CML; Moreira DRM; Lima MDCA
Bioorg Med Chem; 2018 Nov; 26(20):5388-5396. PubMed ID: 30293795
[TBL] [Abstract][Full Text] [Related]
93. Discovery of novel pyrazole and pyrazolo[1,5-a]pyrimidine derivatives as cyclooxygenase inhibitors (COX-1 and COX-2) using molecular modeling simulation.
Ayman R; Radwan AM; Elmetwally AM; Ammar YA; Ragab A
Arch Pharm (Weinheim); 2023 Feb; 356(2):e2200395. PubMed ID: 36336646
[TBL] [Abstract][Full Text] [Related]
94. Synthesis of novel N-substitutedphenyl-6-oxo-3-phenylpyridazine derivatives as cyclooxygenase-2 inhibitors.
Khan A; Diwan A; Thabet HK; Imran M
Drug Dev Res; 2020 Aug; 81(5):573-584. PubMed ID: 32173897
[TBL] [Abstract][Full Text] [Related]
95. Synthesis of new 2,3-dihydroquinazolin-4(1H)-one derivatives for analgesic and anti-inflammatory evaluation.
El-Sabbagh OI; Ibrahim SM; Baraka MM; Kothayer H
Arch Pharm (Weinheim); 2010 May; 343(5):274-81. PubMed ID: 20232372
[TBL] [Abstract][Full Text] [Related]
96. 1,4-Dihydroquinazolin-3(2H)-yl benzamide derivatives as anti-inflammatory and analgesic agents with an improved gastric profile: Design, synthesis, COX-1/2 inhibitory activity and molecular docking study.
Sakr A; Kothayer H; Ibrahim SM; Baraka MM; Rezq S
Bioorg Chem; 2019 Mar; 84():76-86. PubMed ID: 30481648
[TBL] [Abstract][Full Text] [Related]
97. Thiohydantoin derivatives incorporating a pyrazole core: Design, synthesis and biological evaluation as dual inhibitors of topoisomerase-I and cycloxygenase-2 with anti-cancer and anti-inflammatory activities.
Abdellatif KRA; Fadaly WAA; Mostafa YA; Zaher DM; Omar HA
Bioorg Chem; 2019 Oct; 91():103132. PubMed ID: 31374529
[TBL] [Abstract][Full Text] [Related]
98. Synthesis, molecular docking and biological evaluation of some newer 2-substituted-4-(benzo[d][1,3]dioxol-5-yl)-6-phenylpyridazin-3(2H)-ones as potential anti-inflammatory and analgesic agents.
Singh J; Saini V; Kumar A; Bansal R
Bioorg Chem; 2017 Apr; 71():201-210. PubMed ID: 28236449
[TBL] [Abstract][Full Text] [Related]
99. Synthesis and antiinflammatory activity of some new 1,3,5-trisubstituted pyrazolines bearing benzene sulfonamide.
Rathish IG; Javed K; Ahmad S; Bano S; Alam MS; Pillai KK; Singh S; Bagchi V
Bioorg Med Chem Lett; 2009 Jan; 19(1):255-8. PubMed ID: 19010670
[TBL] [Abstract][Full Text] [Related]
100. Design, synthesis, characterization and anti-inflammatory evaluation of novel pyrazole amalgamated flavones.
Chavan HV; Bandgar BP; Adsul LK; Dhakane VD; Bhale PS; Thakare VN; Masand V
Bioorg Med Chem Lett; 2013 Mar; 23(5):1315-21. PubMed ID: 23357629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
